Vancomycin: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>David E. Volk No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
==Pharmacology== | ==Pharmacology== | ||
The half life in normal individuals is 4-6 hours.<ref name="DailyMed-Vancomycin">{{cite web |url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3625 |title=vancomycin hydrochloride (Vancomycin Hydrochloride) injection, solution|author=DailyMed|accessdate=2008-01-06 |format= |work=}}</ref> | The half life in normal individuals is 4-6 hours.<ref name="DailyMed-Vancomycin">{{cite web |url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3625 |title=vancomycin hydrochloride (Vancomycin Hydrochloride) injection, solution|author=DailyMed|accessdate=2008-01-06 |format= |work=}}</ref> | ||
| Line 14: | Line 15: | ||
==External links== | ==External links== | ||
{{DailyMed|3625|vancomycin for injection}} | {{DailyMed|3625|vancomycin for injection}} | ||
Revision as of 15:44, 12 January 2008
Pharmacology
The half life in normal individuals is 4-6 hours.[1]
Adverse effects
Thrombocytopenia
Vancomycin may cause immune thrombocytopenia.[2]
Acute kidney injury
Vancomycin is associated with acute kidney injury if trough levels are above 15 microg/mL.[3] To avoid this, the blood levels of vancomycin should be monitored.[4][5]
References
- ↑ DailyMed. vancomycin hydrochloride (Vancomycin Hydrochloride) injection, solution. Retrieved on 2008-01-06.
- ↑ Von Drygalski A, Curtis BR, Bougie DW, et al (2007). "Vancomycin-induced immune thrombocytopenia". N. Engl. J. Med. 356 (9): 904–10. DOI:10.1056/NEJMoa065066. PMID 17329697. Research Blogging.
- ↑ Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A (2006). "High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity". Arch. Intern. Med. 166 (19): 2138–44. DOI:10.1001/archinte.166.19.2138. PMID 17060545. Research Blogging.
- ↑ Welty TE, Copa AK (1994). "Impact of vancomycin therapeutic drug monitoring on patient care". Ann Pharmacother 28 (12): 1335–9. PMID 7696720. [e]
- ↑ Iwamoto T, Kagawa Y, Kojima M (2003). "Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin". Biol. Pharm. Bull. 26 (6): 876–9. PMID 12808304. [e]
External links
for injection 3625 - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).